EYA3 and Miyoshi myopathy: Bortezomib treatment is known to reduce DNA repair capabilities in MM28 and bortezomib-resistant MM samples in our cohort showed increased EYA3 expression levels, suggesting increased EYA3 expression might help MM cells survive bortezomib-induced genotoxic stress.